LEADER 03029nam  22004933a 450 
001 9910346691103321
005 20250203235428.0
010   $a9783038979135
010   $a3038979139
024 8 $a10.3390/books978-3-03897-913-5
035   $a(CKB)4920000000094758
035   $a(oapen)https://directory.doabooks.org/handle/20.500.12854/46161
035   $a(ScCtBLL)bd93bd72-a122-4789-b4ab-da11da7c60da
035   $a(OCoLC)1126203902
035   $a(oapen)doab46161
035   $a(EXLCZ)994920000000094758
100   $a20250203i20192019  uu 
101 0 $aeng
135   $aurmn|---annan
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aElectrospun and Electrosprayed Formulations for Drug Delivery$fIan S. Blagbrough, Gareth R. Williams
210   $cMDPI - Multidisciplinary Digital Publishing Institute$d2019
210  1$aBasel, Switzerland :$cMDPI,$d2019.
215   $a1 electronic resource (190 p.)
311 08$a9783038979128 
311 08$a3038979120 
330   $aThis book is comprised of important reviews and cutting-edge original research papers concerning electrospun and electrosprayed formulations in drug delivery. Electrospinning and electrospraying have, in recent years, attracted increasing attention in the pharmaceutical sector, with research in the area advancing rapidly. It is now possible to prepare extremely complex systems using multi-fluid processes, and to increase production rates to an industrial scale. Electrospun formulations can be produced under GMP conditions and are in clinical trials. In this volume, we explore a range of topics around electrospinning and electrospraying in controlled drug delivery. Four reviews cover the exciting potential of cyclodextrin-containing fibers and the many potential biomedical applications of electrospun fibers. The use of electrospinning to prepare amorphous systems and improve the dissolution rate and solubility of poorly soluble active ingredients is addressed, and the possibilities of such materials in tissue engineering are comprehensively covered. The six original research papers cover the effect of molecular properties on API release from Eudragit-based electrospun fibers; ferulic acid solid dispersions; electrospun medicines to treat psoriasis; scale up of electrospinning and its use to produce low-dose tablets; transepithelial permeation of drugs released from electrospun fibers, and the possibilities for the synergistic chemophotothermal treatment of cancer.
606   $aDrug delivery systems
606   $aElectrospinning
606   $aNanoparticles
615  0$aDrug delivery systems.
615  0$aElectrospinning.
615  0$aNanoparticles.
676   $a615.1/9
700   $aBlagbrough$b Ian S$01786942
702   $aWilliams$b Gareth R
801  0$bScCtBLL
801  1$bScCtBLL
906   $aBOOK
912   $a9910346691103321
996   $aElectrospun and Electrosprayed Formulations for Drug Delivery$94319484
997   $aUNINA